Circular 008/2014: changes to the Misuse of Drugs Act 1971

The changes under the act cover control of NBOMe and benzofuran compounds, lisdexamphetamine, zopiclone, zaleplon, tramadol and reclassification of ketamine.


Circular 008/2014


  • broad subject: Crime and disorder
  • sub category: Drug offences
  • implementation date: 10 June 2014
  • from: Crime and Policing Group – Drugs and Alcohol Unit
  • for more information contact: Desmond Niimoi at or on 020 7035 3533
  • addressed to: Chief Officers of Police (England and Wales), Chief Officer of Police (Northern Ireland), Chief Officers of Police (Scotland), Clerks to the Police Authorities, Chief Executive of HM Courts & Tribunals Service, Director of Crime, Delivery Directors, Heads of Crime, Cluster Managers, Regional Support Units, Crown Court staff, Magistrates’ Court staff, Clerks to the Justices, Royal Courts of Justice - Court of Appeal (Criminal Division) staff, Lord Chief Justice, President of the Queen’s Bench Division, Senior Presiding Judge for England and Wales, Lords Justices of Appeal, Presiding Judges, High Court Judges, Queen’s Bench Division, Crown Court Judges, Resident Judges, District Judges (Magistrates’ Courts), Chairmen of the Justices, Council of Circuit Judges

This circular draws attention to the contents of the the following statutory instruments:

  • Misuse of Drugs Act 1971 (Ketamine Etc.) (Amendment) Order 2014 (S.I. 2014/1106)
  • Misuse of Drugs and the Misuse of Drugs (Safe Custody) (Amendment) (England, Wales and Scotland) Regulations 2014 (S.I. 2014/1275)
  • Misuse of Drugs (Designation) (Amendment) (England, Wales and Scotland) Order 2014 (S.I. 2014/1274)

which come into force at 00:01 on 10 June 2014.

The accompanying attachment presents the cicrular in full, which covers:

  • The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014
  • NBOMe compounds
  • benzofuran compounds
  • lisdexamphetamine
  • tramadol
  • zopiclone and zaleplon
  • annex A
Published 2 June 2014